Circle Pharma CFO Playbook: Close Q4 FP&A & IR Deals

Do not index

🚀 Battle Card: Circle Pharma, Inc.

Quick trigger:

👤 Decision Maker in the News

Rob Lauzen, Chief Financial Officer · 🔗 LinkedIn

💡 Why It Matters

Capitalize on this Circle Pharma sales trigger: new finance leadership kicks in as they push CID-078 into Phase 1 and prep for the next financing wave. → Source

🎯 Core Pain Point

Fragmented financial reporting slows down fundraising cycles

Lack of real-time visibility into R&D spend

💰 What to Pitch

Primary: FP&A platform → Real-time forecasting & budgeting accuracy

Expansion: Investor Relations portal → Transparent stakeholder communications & compliance

🗺️ Quick Context

HQ: South San Francisco, CA

Employees: ≈ 50

Rev: ≈ $5 M

Website: circlepharma.com

🤼 Competitive Intel

*Which other vendors you’ll probably face to win **Circle Pharma, Inc.*’s business.

Workday — Financial Management

Unique edge: Unified HR & finance data
Evaluated by CFO & VP Finance for scalability

Oracle — ERP / Financial Management

Unique edge: Integrated capital planning
Evaluated by Finance team for end-to-end visibility

SAP — ERP / Financials

Unique edge: Global regulatory compliance
Evaluated by Controller for audit readiness

Sage Intacct — Cloud Accounting

Unique edge: Modular cloud-native design
Evaluated by FP&A for ease of integration

✅ Do-Now Checklist

Connect with Rob Lauzen on LinkedIn (link above)

Reference the Circle Pharma sales trigger in your first touch to stand out

Slot FP&A & IR platform demos into Rob’s Q4 calendar

Schedule follow-ups in CRM (Day 3 & Day 10)

Next Step

Turn every Circle Pharma sales trigger into revenue—fast. Subscribe to NewsletterForLeads

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑<your company>❑
OFFER_BRIEF   = ❑FP&A platform for real-time forecasting & budgeting accuracy❑
PROOF_METRIC  = ❑25% reduction in budget variance❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Rob Lauzen
COMPANY     = Circle Pharma, Inc.
DEPT        = Finance
SIZE        = ≈50
BOTTLENECK  = fragmented financial reporting
EVENT       = Appoints Rob Lauzen as Chief Financial Officer
DETAIL      = pushing CID-078 into Phase 1 clinical development
PAIN        = Lack of real-time visibility into R&D spend
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251031045482&div=41152219
SIM_CO      = Prilenia Therapeutics
WIN_METRIC  = 30% faster budgeting cycles
NEXT_SIZE   = 100
EMP_EST     = ≈ 50
REV_EST     = ≈ $5 M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈50-person Finance

Rob Lauzen—noticed your Finance team is ≈50.

That’s when fragmented financial reporting slows growth.

We helped Prilenia Therapeutics fix this with FP&A platform for real-time forecasting & budgeting accuracy.

Result: 30% faster budgeting cycles.  
Quick call?

PS—next bottleneck hits ≈100.

DM ≤45 words, TONE:
Saw your post about pushing CID-078 into Phase 1 clinical development — Lack of real-time visibility into R&D spend.  
FP&A platform for real-time forecasting & budgeting accuracy. 25% reduction in budget variance. Quick chat?